Over-expression of CCS in G93A SOD1 mice accelerates neurological disease and enhances mitochondrial pathology. We studied the effect of CCS over-expression in transgenic mice expressing G37R, G86R or L126Z SOD1 mutations in order to understand factors which influence mitochondrial dysfunction. Over-expression of CCS markedly decreased survival and produced mitochondrial vacuolation in G37R SOD1 mice but not in G86R or L126Z SOD1 mice. Moreover, CCS/G37R SOD1 spinal cord showed specific reductions in mitochondrial complex IV subunits consistent with an isolated COX deficiency, while no such reductions were detected in CCS/G86R or CCS/L126Z SOD1 mice. CCS over-expression increased the ratio of reduced to oxidized SOD1 monomers in the spinal cords of G37R SOD1 as well as G93A SOD1 mice, but did not influence the redox state of G86R or L126Z SOD1 monomers. The effects of CCS on disease are SOD1 mutation dependent and correlate with SOD1 redox susceptibility.
Over-expression of CCS in G93A SOD1 mice accelerates neurological disease and enhances mitochondrial pathology. We studied the effect of CCS over-expression in transgenic mice expressing G37R, G86R or L126Z SOD1 mutations in order to understand factors which influence mitochondrial dysfunction. Over-expression of CCS markedly decreased survival and produced mitochondrial vacuolation in G37R SOD1 mice but not in G86R or L126Z SOD1 mice. Moreover, CCS/G37R SOD1 spinal cord showed specific reductions in mitochondrial complex IV subunits consistent with an isolated COX deficiency, while no such reductions were detected in CCS/G86R or CCS/L126Z SOD1 mice. CCS over-expression increased the ratio of reduced to oxidized SOD1 monomers in the spinal cords of G37R SOD1 as well as G93A SOD1 mice, but did not influence the redox state of G86R or L126Z SOD1 monomers. The effects of CCS on disease are SOD1 mutation dependent and correlate with SOD1 redox susceptibility.
© 2009 Elsevier Inc. All rights reserved.
There is increasing evidence that mitochondrial dysfunction may be important in the pathogenesis of familial amyotrophic lateral sclerosis (FALS) related to Cu, Zn superoxide dismutase (SOD1) mutations (Manfredi and Xu, 2005; Martin et al., 2007) . Mitochondrial pathology, characterized by vacuolization, is a principal finding in G93A SOD1 transgenic mice that develop motor weakness (Dal Canto and Gurney, 1994) . SOD1 has been detected within mitochondria raising the possibility of a direct toxic effect of G93A SOD1 on mitochondrial function (Okado-Matsumoto and Fridovich, 2001; Vijayvergiya et al., 2005) . Copper chaperone for SOD1 (CCS) overexpression in G93A SOD1 mice increases mutant SOD1 levels within mitochondria, greatly accelerating disease course and enhancing mitochondrial vacuolar pathology (Son et al., 2007) . Spinal cords from dual CCS/G93A SOD1 mice manifest isolated cytochrome c oxidase (COX) deficiency, which may underlie a substantial part of the mitochondrial cytopathy (Son et al., 2008) .
Although G93A SOD1 likely impacts mitochondrial function, in vivo evidence of direct mitochondrial toxicity for other SOD1 mutations is less complete. Sub-cellular fractionation studies have confirmed that other SOD1 mutants, including G37R, G85R, H46R/ H48Q or L126Z SOD1, also accumulate with mitochondria and thus are capable of directly altering mitochondrial function (Liu et al., 2004; Deng et al., 2006) . However, mitochondrial pathology varies greatly among transgenic mouse lines harboring different SOD1 mutations, possibly reflecting varied degrees of mitochondrial involvement in the disease process. Transgenic mice expressing G37R SOD1 develop marked mitochondrial vacuolar pathology, while L126Z, G85R (G86R in mouse), or H46R/H48Q SOD1 mice show little or no mitochondrial pathology (Wong et al., 1995; Bruijn et al., 1997; Wang et al., 2002 Wang et al., , 2005 . The basis for this difference among the transgenic lines is not well understood. Steady state levels of G93A SOD1 and G37R SOD1 within spinal cord are several fold higher than levels of G85R or L126Z SOD1, suggesting that mutant SOD1 protein overloading may lead to mitochondrial dysfunction (Bergemalm et al., 2006) . However, because G37R SOD1 and H46R/H48Q SOD1 mice express similar high steady state SOD1 levels yet manifest different pathologies, factors other than protein loading influence the extent of mitochondrial pathology (Wang et al., 2002) . SOD1 mutants differ in important biochemical parameters including copper binding, disulfide bond formation, or aggregation potential that may affect SOD1 structure and its ability to interact with other proteins which would promote mitochondrial toxicity (Furukawa and O'Halloran, 2005; Krishnan et al., 2006; Wang et al., 2007; Vande Velde et al., 2008) . We therefore crossed CCS transgenic mice with mice expressing various SOD1 mutations to better understand factors which influence mitochondrial pathology. CCS/G37R SOD1 mice show marked acceleration of neurological disease and enhancement of mitochondrial pathology. 
